SlideShare a Scribd company logo
School of Psychology
FACULTY OF MEDICINE AND HEALTH
Improving health information to promote health literacy
Factors influencing the perception of side
effect risk information – reflections and
prospects for research
Peter Gardner
Senior Lecturer and Head of School
School of Psychology
p.h.gardner@leeds.ac.uk
Patient Information Leaflets
(PILs)
Getting better…?
Which parts of the leaflet do
people read?
Side effects 96%
How and when to take it 91%
What is your medicine for? 85%
Things to do before you take 66%
What is in your medicine? 53%
MORI Survey for Medicines Partnership, 2003, 2004
Ask about Medicines Week
Testing the EU terms
EU People
Very common > 10% 54%
Common 1 - 10% 34%
Uncommon 0.1 - 1% 11%
Rare 0.01 - 0.1% 8%
Very rare < 0.01% 4%
Knapp, Raynor, Berry (2004) Quality & Safety in Health Care.
Berry, Knapp, Raynor (2002) Lancet.
What about online Information?
Using a pop-up on a medicine page of Cancerhelp.org.uk
(now ‘About Cancer’ pages)
• 8 on-line studies since 2004
• Publications in British Journal of Health Psychology, Drug Safety, Patient Education
and Counseling, Health Expectations.
• Tested alternative formats for presenting side effect risk on perceptions
of risk
• Controlled design with random allocation
• Taxol, Ibuprofen, Tamoxifen
• Approximately 15 participants per month
• Participants more likely to have a personal interest
Cancer Research UK studies
Background
• Broadly, the suite of studies have tested the effect of
stating the risk of side effects as verbal descriptors,
percentages and frequency statements and combinations
of these formats.
• Started off with the premise that ‘Natural Frequencies’ are
more concrete and would probably work better
• e.g. If 100 people took this medicine, 3 would get
constipation.
Cancer Research UK studies
Findings
• The evidence suggests that verbal descriptors (“common”/
“rare”) on their own produce markedly less accurate
estimations of risk
• Percentages generally perform well, but some evidence
that these are not so good for low risks
• More specific statements about frequency show some
superiority over frequency bands (“affects more than 1 in
10 patients”) but may not be so feasible
• People prefer combined statements (“affects 1 in 500
people (0.2%)”) but are no more accurate in their
estimation of risk
Cancer Research UK studies
Impact
Cancer Research UK studies
Latest study
Testing EMA recommendations
• EMA requires a combination of words and frequency
bands
Common: may affect up to 1 in 10 people
• NICE suggest that verbal descriptors should not be used
without numerical information
• It could be argued that these recommendations are on the
basis of consensus, not evidence
Testing EMA recommendations
• Two questions:
• Does the use of the verbal descriptor ‘frame’ patients’
understanding leading to overestimation of risk?
• Does the use of two indicators of uncertainty lead to
confusion?
‘may affect’ and ‘up to 1 in 10’
• Compare with
‘will affect’ and ‘up to 1 in 10’
Testing EMA recommendations
• 2 x 2 factorial design
• Numerical format vs. Combined verbal and numerical
• ‘will affect’ vs. ‘may affect’
• Presented with information on 10 potential side effects; 2
each from the 5 EC frequency bands
• Asked to provide risk estimates for 5 of the side effects; 1
from each of the bandings
Scenario
Testing EMA recommendations
• 339 participants
• Numerical + may = 91
• Combined + may = 85
• Numerical + will = 77
• Combined + will = 86
Participants
Testing EMA recommendations
• Asked to provide risk estimates for 5 of the side effects; 1
from each of the bandings and a rating of the perceived
risk of experiencing ANY of the side effects
• Also completed 5 Likert scales regarding:
• Satisfaction with the information
• Severity of the side effects
• Likelihood of experiencing a side effect
• General risk to health
• Effect on decision to continue treatment
Results
Numerical vs. Combined
Results
• No differences between ‘may’ and ‘will’ conditions on
perceptions of side effect risk
• Little difference in Likert ratings between the conditions
• Higher perceived likelihood of experiencing side effects in the combined
condition
• No evidence of interactions between the variables
Results
‘May’ vs. ‘Will’
Conclusions
• Possible framing effect of verbal descriptors
• Variability of response suggests lack of shared
understanding of risk descriptions
• Problem of overestimation still prevalent in ‘numerical
only’ condition, but…
• Low incidence rates mean that people are more likely to overestimate than
underestimate
• Heterogeneity of risk perception responses may mean it is impossible to
get shared understanding
• Precise risk information is difficult to obtain anyway
Future research
• Need for replication of findings with different medicines
• Are there other factors involved?
• Numeracy (see Gardner et al, 2011)
• Other individual differences
• Emotional reaction to different types of treatment
• Need to investigate the effect on actual behaviour
References
Berry, D.C., Knapp, P. and Raynor, D.K. (2002). Provision of information about drug side effects to
patients. Lancet, 359, 853-4.
Gardner, P.H., McMillan, B.R.W., Raynor, D.K., Woolf, E., Knapp, P. (2011). The effect of numeracy on the
comprehension of information about medicines in users of a patient information website. Patient
Education and Counseling, 83, 398-403.
Knapp, P., Gardner P.H., Carrigan N., Raynor, D.K. and Woolf, E. (2009). Perceived risk of medicine side
effects in users of a patient information website: a study of the use of verbal descriptors, percentages
and natural frequencies. British Journal of Health Psychology,14, 579-94.
Knapp, P., Gardner, P.H., Raynor, D.K., Woolf, E. and McMillan, B.R.W. (2010). Perceived risk of
Tamoxifen side effects: a study of the use of absolute frequencies or frequency bands, with or without
verbal descriptors. Patient Education and Counseling, 79(2), 267-271.
Knapp, P.R., Gardner, P.H. and Woolf, E. (2015). Combined verbal and numerical expressions increase
perceived risk of medicine side-effects: a randomized controlled trial of EMA recommendations. Health
Expectations, published online 26 Jan 2015, doi: 10.1111/hex.12344.
Knapp, P., Raynor, D.K. and Berry, D.C. (2004). Comparison of two methods of presenting risk information
to patients about the side effects of medicines. Quality and Safety in Health Care,13, 176-80.
Knapp, P., Raynor, D.K., Woolf, E., Gardner, P.H., Carrigan, N. and McMillan, B.R.W. (2009).
Communicating the risk of side effects to patients: an evaluation of UK regulatory recommendations.
Drug Safety, 32(10), 837-849.

More Related Content

What's hot

Description and Analysis some adj
Description and Analysis  some adjDescription and Analysis  some adj
Description and Analysis some adj
Erin Dinkel
 
HSRPP 2015 IJPP pain
HSRPP 2015 IJPP painHSRPP 2015 IJPP pain
HSRPP 2015 IJPP pain
Joyce McSwan
 
Nicotine Tob Res-2016-Chidiac-ntr_ntw250
Nicotine Tob Res-2016-Chidiac-ntr_ntw250Nicotine Tob Res-2016-Chidiac-ntr_ntw250
Nicotine Tob Res-2016-Chidiac-ntr_ntw250
Joseph Chidiac
 
Impact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy AdherenceImpact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy Adherence
Yayra Nyoagbe
 

What's hot (20)

Risk Communication and Medical Decision Making
Risk Communication  and Medical Decision MakingRisk Communication  and Medical Decision Making
Risk Communication and Medical Decision Making
 
HL7: Clinical Decision Support
HL7: Clinical Decision SupportHL7: Clinical Decision Support
HL7: Clinical Decision Support
 
Making evidence accessible to clinicians
Making evidence accessible to cliniciansMaking evidence accessible to clinicians
Making evidence accessible to clinicians
 
The drug effectiveness review project: governments collaborating to use syste...
The drug effectiveness review project: governments collaborating to use syste...The drug effectiveness review project: governments collaborating to use syste...
The drug effectiveness review project: governments collaborating to use syste...
 
Description and Analysis some adj
Description and Analysis  some adjDescription and Analysis  some adj
Description and Analysis some adj
 
mohammed aiyaz
mohammed aiyazmohammed aiyaz
mohammed aiyaz
 
10.1007_s11096-016-0258-9
10.1007_s11096-016-0258-910.1007_s11096-016-0258-9
10.1007_s11096-016-0258-9
 
Oncology and Psycho-Oncology
Oncology and Psycho-OncologyOncology and Psycho-Oncology
Oncology and Psycho-Oncology
 
HSRPP 2015 IJPP pain
HSRPP 2015 IJPP painHSRPP 2015 IJPP pain
HSRPP 2015 IJPP pain
 
Path a Manualized Program for HIV Prevention with Persons with Mental Illness...
Path a Manualized Program for HIV Prevention with Persons with Mental Illness...Path a Manualized Program for HIV Prevention with Persons with Mental Illness...
Path a Manualized Program for HIV Prevention with Persons with Mental Illness...
 
Communicating hope and truth: A presentation for health care professionals
Communicating hope and truth: A presentation for health care professionalsCommunicating hope and truth: A presentation for health care professionals
Communicating hope and truth: A presentation for health care professionals
 
Staff Meeting Breakout of HIV Prevention Topics
Staff Meeting Breakout of HIV Prevention TopicsStaff Meeting Breakout of HIV Prevention Topics
Staff Meeting Breakout of HIV Prevention Topics
 
Genetic testing evaluation part 1 2018
Genetic testing evaluation part 1 2018Genetic testing evaluation part 1 2018
Genetic testing evaluation part 1 2018
 
Absolute Final PIP poster!!
Absolute Final PIP poster!!Absolute Final PIP poster!!
Absolute Final PIP poster!!
 
Quality And Performamce Measurement: The Massachusetts Experience
Quality And Performamce Measurement: The Massachusetts ExperienceQuality And Performamce Measurement: The Massachusetts Experience
Quality And Performamce Measurement: The Massachusetts Experience
 
Gene therapy presentation
Gene therapy presentationGene therapy presentation
Gene therapy presentation
 
Nicotine Tob Res-2016-Chidiac-ntr_ntw250
Nicotine Tob Res-2016-Chidiac-ntr_ntw250Nicotine Tob Res-2016-Chidiac-ntr_ntw250
Nicotine Tob Res-2016-Chidiac-ntr_ntw250
 
An overview of deprescribing
An overview of deprescribingAn overview of deprescribing
An overview of deprescribing
 
Isaacus torkamani 011118
Isaacus torkamani 011118Isaacus torkamani 011118
Isaacus torkamani 011118
 
Impact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy AdherenceImpact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy Adherence
 

Similar to Factors influencing the perception of side-effect risk information - reflections and prospects for research

Risk Communication
Risk CommunicationRisk Communication
Risk Communication
DrNeilArnott
 
Alzheimer
AlzheimerAlzheimer
Alzheimer
Harold
 
Identification and Characterization of Drug (3)
Identification and Characterization of Drug (3)Identification and Characterization of Drug (3)
Identification and Characterization of Drug (3)
Alina Amitai ????? ?????
 

Similar to Factors influencing the perception of side-effect risk information - reflections and prospects for research (20)

DFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practiceDFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practice
 
Risky Business: Risk communicat ion in the provider-patient encounter
Risky Business: Risk communicat ion in the provider-patient encounterRisky Business: Risk communicat ion in the provider-patient encounter
Risky Business: Risk communicat ion in the provider-patient encounter
 
Risk Communication
Risk CommunicationRisk Communication
Risk Communication
 
Msrc types research (1)
Msrc types research (1)Msrc types research (1)
Msrc types research (1)
 
Evidence to Decision tables – 11th CE&B's research day presentation
Evidence to Decision tables – 11th CE&B's research day presentationEvidence to Decision tables – 11th CE&B's research day presentation
Evidence to Decision tables – 11th CE&B's research day presentation
 
International Journal of Reproductive Medicine & Gynecology
International Journal of Reproductive Medicine & GynecologyInternational Journal of Reproductive Medicine & Gynecology
International Journal of Reproductive Medicine & Gynecology
 
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
 
Alzheimer
AlzheimerAlzheimer
Alzheimer
 
Green
GreenGreen
Green
 
Fetal monitoring rcog
Fetal monitoring rcogFetal monitoring rcog
Fetal monitoring rcog
 
Introduction to biostatistics
Introduction to biostatisticsIntroduction to biostatistics
Introduction to biostatistics
 
An Internet questionnaire to identify Drug seeking behavior in a patient in t...
An Internet questionnaire to identify Drug seeking behavior in a patient in t...An Internet questionnaire to identify Drug seeking behavior in a patient in t...
An Internet questionnaire to identify Drug seeking behavior in a patient in t...
 
Pain Validity Test to detect drug seeking behavior
Pain Validity Test to detect drug seeking behaviorPain Validity Test to detect drug seeking behavior
Pain Validity Test to detect drug seeking behavior
 
Pain Validity Test identifies drug seeking behavior. Stop opioid abuse. Prote...
Pain Validity Test identifies drug seeking behavior. Stop opioid abuse. Prote...Pain Validity Test identifies drug seeking behavior. Stop opioid abuse. Prote...
Pain Validity Test identifies drug seeking behavior. Stop opioid abuse. Prote...
 
Identification and Characterization of Drug (3)
Identification and Characterization of Drug (3)Identification and Characterization of Drug (3)
Identification and Characterization of Drug (3)
 
Hazard Identification
Hazard IdentificationHazard Identification
Hazard Identification
 
Clinical Trials, Epidemiology and Biostatistics in Skin Disease
Clinical Trials, Epidemiology and Biostatistics in Skin DiseaseClinical Trials, Epidemiology and Biostatistics in Skin Disease
Clinical Trials, Epidemiology and Biostatistics in Skin Disease
 
Article 1527760801
Article 1527760801 Article 1527760801
Article 1527760801
 
Session 5.4: Moody
Session 5.4: MoodySession 5.4: Moody
Session 5.4: Moody
 
Session 5.4 Moody
Session 5.4 MoodySession 5.4 Moody
Session 5.4 Moody
 

More from HLGUK

More from HLGUK (10)

Widening Digital Participation
Widening Digital Participation Widening Digital Participation
Widening Digital Participation
 
Don redding health literacy and the reforms
Don redding health literacy and the reformsDon redding health literacy and the reforms
Don redding health literacy and the reforms
 
Adrian sieff
Adrian sieffAdrian sieff
Adrian sieff
 
Gill Rowlands Heath Literacy - Making it Everybody's Business
Gill Rowlands Heath Literacy - Making it Everybody's BusinessGill Rowlands Heath Literacy - Making it Everybody's Business
Gill Rowlands Heath Literacy - Making it Everybody's Business
 
Jo Protheroe - Health Literacy and Health Inequality
Jo Protheroe - Health Literacy and Health InequalityJo Protheroe - Health Literacy and Health Inequality
Jo Protheroe - Health Literacy and Health Inequality
 
Improving Health Literacy to Reduce Health Inequalities
Improving Health Literacy to Reduce Health InequalitiesImproving Health Literacy to Reduce Health Inequalities
Improving Health Literacy to Reduce Health Inequalities
 
Information Standard presentation
Information Standard presentationInformation Standard presentation
Information Standard presentation
 
The Information Standard
The Information StandardThe Information Standard
The Information Standard
 
Health literacy and health information in England: how big is the problem?
Health literacy and health information in England: how big is the problem?Health literacy and health information in England: how big is the problem?
Health literacy and health information in England: how big is the problem?
 
What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
FatimaMary4
 

Recently uploaded (20)

Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
 
Contact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdfContact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdf
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 

Factors influencing the perception of side-effect risk information - reflections and prospects for research

  • 1. School of Psychology FACULTY OF MEDICINE AND HEALTH Improving health information to promote health literacy Factors influencing the perception of side effect risk information – reflections and prospects for research Peter Gardner Senior Lecturer and Head of School School of Psychology p.h.gardner@leeds.ac.uk
  • 4. Which parts of the leaflet do people read? Side effects 96% How and when to take it 91% What is your medicine for? 85% Things to do before you take 66% What is in your medicine? 53% MORI Survey for Medicines Partnership, 2003, 2004 Ask about Medicines Week
  • 5. Testing the EU terms EU People Very common > 10% 54% Common 1 - 10% 34% Uncommon 0.1 - 1% 11% Rare 0.01 - 0.1% 8% Very rare < 0.01% 4% Knapp, Raynor, Berry (2004) Quality & Safety in Health Care. Berry, Knapp, Raynor (2002) Lancet.
  • 6. What about online Information? Using a pop-up on a medicine page of Cancerhelp.org.uk (now ‘About Cancer’ pages) • 8 on-line studies since 2004 • Publications in British Journal of Health Psychology, Drug Safety, Patient Education and Counseling, Health Expectations. • Tested alternative formats for presenting side effect risk on perceptions of risk • Controlled design with random allocation • Taxol, Ibuprofen, Tamoxifen • Approximately 15 participants per month • Participants more likely to have a personal interest
  • 7. Cancer Research UK studies Background • Broadly, the suite of studies have tested the effect of stating the risk of side effects as verbal descriptors, percentages and frequency statements and combinations of these formats. • Started off with the premise that ‘Natural Frequencies’ are more concrete and would probably work better • e.g. If 100 people took this medicine, 3 would get constipation.
  • 8. Cancer Research UK studies Findings • The evidence suggests that verbal descriptors (“common”/ “rare”) on their own produce markedly less accurate estimations of risk • Percentages generally perform well, but some evidence that these are not so good for low risks • More specific statements about frequency show some superiority over frequency bands (“affects more than 1 in 10 patients”) but may not be so feasible • People prefer combined statements (“affects 1 in 500 people (0.2%)”) but are no more accurate in their estimation of risk
  • 9. Cancer Research UK studies Impact
  • 10. Cancer Research UK studies Latest study
  • 11. Testing EMA recommendations • EMA requires a combination of words and frequency bands Common: may affect up to 1 in 10 people • NICE suggest that verbal descriptors should not be used without numerical information • It could be argued that these recommendations are on the basis of consensus, not evidence
  • 12. Testing EMA recommendations • Two questions: • Does the use of the verbal descriptor ‘frame’ patients’ understanding leading to overestimation of risk? • Does the use of two indicators of uncertainty lead to confusion? ‘may affect’ and ‘up to 1 in 10’ • Compare with ‘will affect’ and ‘up to 1 in 10’
  • 13. Testing EMA recommendations • 2 x 2 factorial design • Numerical format vs. Combined verbal and numerical • ‘will affect’ vs. ‘may affect’ • Presented with information on 10 potential side effects; 2 each from the 5 EC frequency bands • Asked to provide risk estimates for 5 of the side effects; 1 from each of the bandings
  • 15. Testing EMA recommendations • 339 participants • Numerical + may = 91 • Combined + may = 85 • Numerical + will = 77 • Combined + will = 86
  • 17. Testing EMA recommendations • Asked to provide risk estimates for 5 of the side effects; 1 from each of the bandings and a rating of the perceived risk of experiencing ANY of the side effects • Also completed 5 Likert scales regarding: • Satisfaction with the information • Severity of the side effects • Likelihood of experiencing a side effect • General risk to health • Effect on decision to continue treatment
  • 19. Results • No differences between ‘may’ and ‘will’ conditions on perceptions of side effect risk • Little difference in Likert ratings between the conditions • Higher perceived likelihood of experiencing side effects in the combined condition • No evidence of interactions between the variables
  • 21. Conclusions • Possible framing effect of verbal descriptors • Variability of response suggests lack of shared understanding of risk descriptions • Problem of overestimation still prevalent in ‘numerical only’ condition, but… • Low incidence rates mean that people are more likely to overestimate than underestimate • Heterogeneity of risk perception responses may mean it is impossible to get shared understanding • Precise risk information is difficult to obtain anyway
  • 22. Future research • Need for replication of findings with different medicines • Are there other factors involved? • Numeracy (see Gardner et al, 2011) • Other individual differences • Emotional reaction to different types of treatment • Need to investigate the effect on actual behaviour
  • 23. References Berry, D.C., Knapp, P. and Raynor, D.K. (2002). Provision of information about drug side effects to patients. Lancet, 359, 853-4. Gardner, P.H., McMillan, B.R.W., Raynor, D.K., Woolf, E., Knapp, P. (2011). The effect of numeracy on the comprehension of information about medicines in users of a patient information website. Patient Education and Counseling, 83, 398-403. Knapp, P., Gardner P.H., Carrigan N., Raynor, D.K. and Woolf, E. (2009). Perceived risk of medicine side effects in users of a patient information website: a study of the use of verbal descriptors, percentages and natural frequencies. British Journal of Health Psychology,14, 579-94. Knapp, P., Gardner, P.H., Raynor, D.K., Woolf, E. and McMillan, B.R.W. (2010). Perceived risk of Tamoxifen side effects: a study of the use of absolute frequencies or frequency bands, with or without verbal descriptors. Patient Education and Counseling, 79(2), 267-271. Knapp, P.R., Gardner, P.H. and Woolf, E. (2015). Combined verbal and numerical expressions increase perceived risk of medicine side-effects: a randomized controlled trial of EMA recommendations. Health Expectations, published online 26 Jan 2015, doi: 10.1111/hex.12344. Knapp, P., Raynor, D.K. and Berry, D.C. (2004). Comparison of two methods of presenting risk information to patients about the side effects of medicines. Quality and Safety in Health Care,13, 176-80. Knapp, P., Raynor, D.K., Woolf, E., Gardner, P.H., Carrigan, N. and McMillan, B.R.W. (2009). Communicating the risk of side effects to patients: an evaluation of UK regulatory recommendations. Drug Safety, 32(10), 837-849.